Clinical trialObsRecruiting
Collection of Circulating Biomarkers in Pancreatic Cancer
Protocol to Permit Collection of Circulating Biomarkers in Pancreatic Cancer
- Outcome
- Ongoing
- Phase
- Obs
- Status
- Recruiting
- Study type
- Observational
- Start
- 27 February 2023
- Expected end
- 15 January 2028
- Enrollment
- 30 participants
- Sites
- 1
- Primary outcomes
- To create a comprehensive system to collect, catalogue and store blood specimens from subjects with pancreatic cancer for future research use.
- Sponsor
- Other
- Results posted
- No
- Last update
- 7 April 2026
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
This protocol will involve collection of blood samples from patients with a diagnosis of pancreatic adenocarcinoma for evaluation of circulating biomarkers.